[Asymptomatic multinodular liver disease].
Cadiot
Guillaume
G
Hépato-Gastroentérologie, Hôpital Robert Debré, 51092 Reims Cedex.
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D016461:Chemoembolization, Therapeutic / Q000379:methods; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D019160:Endosonography; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000209:etiology / Q000601:surgery; D008113:Liver Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D008297:Male; D018761:Multiple Endocrine Neoplasia Type 1 / Q000150:complications / Q000473:pathology*; D015282:Octreotide / Q000008:administration & dosage; D010190:Pancreatic Neoplasms / Q000150:complications / Q000473:pathology*; D013004:Somatostatin / Q000031:analogs & derivatives*; D013311:Streptozocin / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D018931:Antineoplastic Agents, Hormonal; D013004:Somatostatin; D013311:Streptozocin; D004317:Doxorubicin; C081788:pentetreotide; D015282:Octreotide